This may be associated with the up-regulation of ENO1 which started at the very earliest neoplastic stage of PDAC [13], increased with the developing of PDAC, and decreased in the peripheral blood by necrosis and turnover of primary tumor cells at the latest stage. The gene discussed is ENO1; the disease is neoplasm.